FILOPANTI, MARCELLO
FILOPANTI, MARCELLO
DIPARTIMENTO DI SCIENZE MEDICHE (attivo dal 01/01/2000 al 27/04/2012)
The role of carboxy-terminal cross-linking telopeptide of type I collagen, dual x-ray absorptiometry bone strain and Romberg test in a new osteoporotic fracture risk evaluation : a proposal from an observational study
2018 F.M. Ulivieri, L.P. Piodi, E. Grossi, L. Rinaudo, C. Messina, A.P. Tassi, M. Filopanti, A. Tirelli, F. Sardanelli
Recurrence of hyperprolactinemia following dopamine agonist withdrawal and possible predictive factors of recurrence in prolactinomas
2016 E. Sala, P. Bellaviti Buttoni, E. Malchiodi, E. Verrua, G. Carosi, E. Profka, G. Rodari, M. Filopanti, E. Ferrante, A. Spada, G. Mantovani
Estimated glomerular filtration rate by serum cystatin C correlates with cardiometabolic parameters in patients with primary hyperparathyroidism
2015 F. Ermetici, M. Filopanti, U. Verga, E. Passeri, G. Dito, A.E. Malavazos, C. Mapelli, M.E. Raggi, A. Spada, S. Corbetta
Hypothalamic-Pituitary Axis in Non-Functioning Pituitary Adenomas : focus on the Prevalence of Isolated Central Hypoadrenalism
2015 G. Carosi, E. Malchiodi, E. Ferrante, E. Sala, E. Verrua, E. Profka, C. Giavoli, M. Filopanti, P. Beck-Peccoz, A. Spada, G. Mantovani
Impact of IGF(CA)19 gene polymorphism on the metabolic response to GH therapy in adult GH-deficient patients
2014 C. Giavoli, E. Profka, E. Sala, M. Filopanti, A.M. Barbieri, S. Bergamaschi, E. Ferrante, M. Arosio, B. Ambrosi, A.G. Lania, A. Spada, P. Beck-Peccoz
Role of IGF1-(CA)19 promoter microsatellite in the clinical presentation of acromegaly
2014 E. Sala, M. Filopanti, E. Ferrante, A.M. Barbieri, E. Malchiodi, E. Verrua, C. Giavoli, A.G. Lania, M. Arosio, P. Beck-Peccoz, A. Spada, G. Mantovani
Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterations
2014 F.M. Elli, L. De Sanctis, V. Bollati, L. Tarantini, M. Filopanti, A.M. Barbieri, E. Peverelli, P. Beck-Peccoz, A. Spada, G. Mantovani
Diagnostic features and outcome of surgical therapy of acromegalic patients : experience of the last three decades
2014 E. Sala, E. Ferrante, M. Locatelli, P. Rampini, G. Mantovani, C. Giavoli, M. Filopanti, E. Verrua, E. Malchiodi, G. Carrabba, M. Arosio, P. Beck-Peccoz, A. Spada, A.G. Lania
Reevaluation of Acromegalic Patients in Long-Term Remission according to Newly Proposed Consensus Criteria for Control of Disease
2014 E. Verrua, E. Ferrante, M. Filopanti, E. Malchiodi, E. Sala, C. Giavoli, M. Arosio, A.G. Lania, C.L. Ronchi, G. Mantovani, P. Beck-Peccoz, A. Spada
Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism
2013 C. Eller-Vainicher, M. Filopanti, S. Palmieri, F.M. Ulivieri, V. Morelli, V.V. Zhukouskaya, E. Cairoli, R. Pino, A. Naccarato, U. Verga, A. Scillitani, P. Beck-Peccoz, I. Chiodini
Pharmacology of the calcium sensing receptor
2013 M. Filopanti, S. Corbetta, A.M. Barbieri, A. Spada
Growth hormone-releasing hormone-producing pancreatic neuroendocrine tumor in a multiple endocrine neoplasia type 1 family with an uncommon phenotype
2013 E. Sala, E. Ferrante, E. Verrua, E. Malchiodi, G. Mantovani, M. Filopanti, S. Ferrero, A. Pietrabissa, A. Vanoli, S. La Rosa, M. Zatelli, P. Beck-Peccoz, U. Verga
MEN1-related hyperparathyroidism : response to cinacalcet and its relationship with the calcium-sensing receptor gene variant Arg990Gly
2012 M. Filopanti, U. Verga, F. Ermetici, L. Olgiati, C. Eller-Vainicher, S. Corbetta, L. Persani, P. Beck Peccoz, A. Spada
Growth hormone receptor variants and response to pegvisomant in monotherapy or in combination with somatostatin analogs in acromegalic patients : a multicenter study
2012 M. Filopanti, L. Olgiati, G. Mantovani, S. Corbetta, M. Arosio, V. Gasco, L. De Marinis, C. Martini, F. Bogazzi, S. Cannavò, A. Colao, D. Ferone, G. Arnaldi, F. Pigliaru, A. Peri, G. Angeletti, M.L. Jaffrain Rea, A.G. Lania, A. Spada
GH response to oral glucose tolerance test : a comparison between patients with acromegaly and other pituitary disorders
2011 E. Verrua, M. Filopanti, C.L. Ronchi, L. Olgiati, E. Ferrante, C. Giavoli, E. Sala, G. Mantovani, M. Arosio, P. Beck Peccoz, A.G. Lania, A. Spada
Double pituitary and conserved function in an adult patient with neurofibromatosis type 1
2011 M. Filopanti, U. Verga, F. Ermetici, F. Natacci, F. Lalatta, S. Avignone, L. Trespidi, P. Beck Peccoz, G. Mantovani, A.G. Lania, A. Spada
Analysis of genetic variants of phosphodiesterase 11A (PDE11A) in acromegalic patients
2009 E. Peverelli, F. Ermetici, M. Filopanti, F. Elli, C. Ronchi, G. Mantovani, S. Ferrero, S. Bosari, P. Beck-Peccoz, A. Lania, A. Spada
Dopamine D2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas
2008 M. Filopanti, A.M. Barbieri, A.R. Angioni, A. Colao, V. Gasco, S. Grottoli, A. Peri, S. Baglioni, M.F. Fustini, F. Pigliaru, P.D. Monte, G. Borretta, B. Ambrosi, M.L. Jaffrain Rea, M. Gasperi, S. Brogioni, S. Cannavò, G. Mantovani, P. Beck Peccoz, A. Lania, A. Spada
Two novel nonsense mutations in GALNT3 gene are responsible for familial tumoral calcinosis
2007 A.M. Barbieri, M. Filopanti, G. Bua, P. Beck-Peccoz
R990G polymorphism of the calcium-sensing receptor and renal calcium excretion in patients with primary hyperparathyroidism
2006 S. Corbetta, C. Eller-Vainicher, M. Filopanti, P. Saeli, G. Vezzoli, T. Arcidiacono, P. Loli, M.L. Syren, L. Soldati, P. Beck-Peccoz, A. Spada